Variant NB.1.8.1 accounted for 0% of U.S. cases in April. By mid-June, it was estimated to be the cause of around 37% of cases.

Newer formulations are even more effective at preventing illnesses that commonly afflict seniors — perhaps even dementia.

At the same time a new COVID variant has been reported in the U.S., residents of Illinois and across the nation will likely ...

The newly reconstituted CDC Advisory Committee on Immunization Practices will meet this week. Packed with antivaxxers, the ...

The elimination of 3,500 full-time employees at the FDA risks undermining the very innovation and domestic capacity the ...

A growing body of research demonstrating the safety and effectiveness of self-managed abortion with pills, coupled with the ...

Makary and Center for Biologics Evaluation and Research Director Vinay Prasad unveiled a new framework in the New England ...

Robert F. Kennedy Jr. (RFK Jr.) has only been Secretary of the Department of Health and Human Services (HHS) since ...

Dr Martin J Tobin discusses health disparities related to pulse oximeter accuracy and the need for improvement to make health care equitable.

Pfizer’s 7%+ yield is tempting, but rising political, regulatory, and business risks threaten its stability and growth ...

A new Lyme disease vaccine, VLA15, is currently being tested and the manufacturers could ask the FDA for authorization as ...

Many smart people reassured us that Dr. Jay Bhattacharya was both qualified to run the NIH and motivated to make it a better place. They should make the case they were right.